Citations (22)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (2)
Albert J. Czaja. (2019) Immune inhibitory proteins and their pathogenic and therapeutic implications in autoimmunity and autoimmune hepatitis. Autoimmunity 52:4, pages 144-160.
Read now
Read now
Ewelina Grywalska, Marcin Pasiarski, Stanisław Góźdź & Jacek Roliński. (2018) Immune-checkpoint inhibitors for combating T-cell dysfunction in cancer. OncoTargets and Therapy 11, pages 6505-6524.
Read now
Read now
Articles from other publishers (20)
Rimlee Dutta, Amber Rathor, Hanuman Prasad Sharma, Hem Chandra Pandey, Prabhat Singh Malik, Anant Mohan, Aruna Nambirajan, Rajeev Kumar & Deepali Jain. (2023) Mapping the immune landscape in small cell lung cancer by analysing expression of immuno-modulators in tissue biopsies and paired blood samples. Scientific Reports 13:1.
Crossref
Crossref
Ayse Engin, Akif Turna, Fehim Esen, Melek Agkoc, Duygu Ilke Cikman, Omer Faruk Saglam, Gunnur Deniz & Esin Cetin Aktas. (2021) Mediastinal lymph node removal ameliorates cytotoxic T-lymphocyte functions in patients with non-small cell lung cancer. Tumori Journal 109:1, pages 97-104.
Crossref
Crossref
Kelsey E. Huntington & Wafik S. El-Deiry. 2022. Handbook of Cancer and Immunology. Handbook of Cancer and Immunology
1
44
.
Wei Teng, Wen‐Juei Jeng, Wei‐Ting Chen, Chen‐Chun Lin, Chun‐Yen Lin, Shi‐Ming Lin & I‐Shyan Sheen. (2022) Soluble form of CTLA‐4 is a good predictor for tumor recurrence after radiofrequency ablation in hepatocellular carcinoma patients. Cancer Medicine 11:20, pages 3786-3795.
Crossref
Crossref
Wenwu He, Xuefeng Leng, Tianqin Mao, Xi Luo, Lingxiao Zhou, Jiaxin Yan, Lin Peng, Qiang Fang, Guangyuan Liu, Xing Wei, Kangning Wang, Chenghao Wang, Sha Zhang, Xudong Zhang, Xudong Shen, Depei Huang, Huan Yi, Ting Bei, Xueke She, Wenguang Xiao & Yongtao Han. (2022) Toripalimab Plus Paclitaxel and Carboplatin as Neoadjuvant Therapy in Locally Advanced Resectable Esophageal Squamous Cell Carcinoma. The Oncologist 27:1, pages e18-e28.
Crossref
Crossref
Ritsuzo Kozuka, Masaru Enomoto, Minh Phuong Dong, Hoang Hai, Le Thi Thanh Thuy, Naoshi Odagiri, Kanako Yoshida, Kohei Kotani, Hiroyuki Motoyama, Etsushi Kawamura, Atsushi Hagihara, Hideki Fujii, Sawako Uchida-Kobayashi, Akihiro Tamori & Norifumi Kawada. (2022) Soluble programmed cell death-1 predicts hepatocellular carcinoma development during nucleoside analogue treatment. Scientific Reports 12:1.
Crossref
Crossref
Jiajia Liu, Xiaoyi Tian, Yan Wang, Xixiong Kang & Wenqi Song. (2021) Soluble cytotoxic T-lymphocyte–associated antigen 4 (sCTLA-4) as a potential biomarker for diagnosis and evaluation of the prognosis in Glioma. BMC Immunology 22:1.
Crossref
Crossref
Muhammad Khan, Sumbal Arooj & Hua Wang. (2021) Soluble B7-CD28 Family Inhibitory Immune Checkpoint Proteins and Anti-Cancer Immunotherapy. Frontiers in Immunology 12.
Crossref
Crossref
Jil M. Jubel, Thomas M. Randau, Janine Becker-Gotot, Sebastian Scheidt, Matthias D. Wimmer, Hendrik Kohlhof, Christof Burger, Dieter C. Wirtz & Frank A. Schildberg. (2021) sCD28, sCD80, sCTLA-4, and sBTLA Are Promising Markers in Diagnostic and Therapeutic Approaches for Aseptic Loosening and Periprosthetic Joint Infection. Frontiers in Immunology 12.
Crossref
Crossref
Kun Deng, Jingwei Yao, Jialu Huang, Yubo Ding & Jianhong Zuo. (2021) Abnormal alternative splicing promotes tumor resistance in targeted therapy and immunotherapy. Translational Oncology 14:6, pages 101077.
Crossref
Crossref
Jieqiong Liu, Ying Li, Qian Li, Dandan Liang, Quanren Wang & Qiang Liu. (2021) Biomarkers of response to camrelizumab combined with apatinib: an analysis from a phase II trial in advanced triple-negative breast cancer patients. Breast Cancer Research and Treatment 186:3, pages 687-697.
Crossref
Crossref
Damiano Verardo, Leena Liljedahl, Corinna Richter, Björn Agnarsson, Ulrika Axelsson, Christelle N. Prinz, Fredrik Höök, Carl A. K. Borrebaeck & Heiner Linke. (2021) Fluorescence Signal Enhancement in Antibody Microarrays Using Lightguiding Nanowires. Nanomaterials 11:1, pages 227.
Crossref
Crossref
Xianghu Jiang, Guohong Liu, Yirong Li & Yunbao Pan. (2021) Immune checkpoint: The novel target for antitumor therapy. Genes & Diseases 8:1, pages 25-37.
Crossref
Crossref
Ana Catarina Urbano, Catarina Nascimento, Maria Soares, Jorge Correia & Fernando Ferreira. (2020) Clinical Relevance of the serum CTLA-4 in Cats with Mammary Carcinoma. Scientific Reports 10:1.
Crossref
Crossref
Minh Phuong Dong, Masaru Enomoto, Le Thi Thanh Thuy, Hoang Hai, Vu Ngoc Hieu, Dinh Viet Hoang, Ayako Iida-Ueno, Naoshi Odagiri, Yuga Amano-Teranishi, Atsushi Hagihara, Hideki Fujii, Sawako Uchida-Kobayashi, Akihiro Tamori & Norifumi Kawada. (2020) Clinical significance of circulating soluble immune checkpoint proteins in sorafenib-treated patients with advanced hepatocellular carcinoma. Scientific Reports 10:1.
Crossref
Crossref
Rituparna Chakrabarti, Bhavya Kapse & Gayatri Mukherjee. (2019) Soluble immune checkpoint molecules: Serum markers for cancer diagnosis and prognosis. CANCER REPORTS, pages e1160.
Crossref
Crossref
Danuta Nowicka, Ewelina Grywalska, Agata Surdacka, Agnieszka Grafka & Jacek Roliński. (2019) Frequencies of PD-1- and PD-L1- positive T CD3+CD4+, T CD3+CD8+ and B CD19+ lymphocytes and its correlations with other immune cells in patients with recurrent furunculosis. Microbial Pathogenesis 126, pages 85-91.
Crossref
Crossref
Maria Pia Pistillo, Vincenzo Fontana, Anna Morabito, Beatrice Dozin, Stefania Laurent, Roberta Carosio, Barbara Banelli, Francesca Ferrero, Laura Spano, Enrica Tanda, Pier Francesco Ferrucci, Chiara Martinoli, Emilia Cocorocchio, Michele Guida, Stefania Tommasi, Federica De Galitiis, Elena Pagani, Gian Carlo Antonini Cappellini, Paolo Marchetti, Pietro Quaglino, Paolo Fava, Simona Osella-Abate, Paolo Antonio Ascierto, Mariaelena Capone, Ester Simeone, Massimo Romani, Francesco Spagnolo & Paola Queirolo. (2018) Soluble CTLA-4 as a favorable predictive biomarker in metastatic melanoma patients treated with ipilimumab: an Italian melanoma intergroup study. Cancer Immunology, Immunotherapy 68:1, pages 97-107.
Crossref
Crossref
Caoimhín O'Higgins, Frank J. Ward & Rasha Abu Eid. (2018) Deciphering the Role of Regulatory CD4 T Cells in Oral and Oropharyngeal Cancer: A Systematic Review. Frontiers in Oncology 8.
Crossref
Crossref
Priscilla Brito da Silva, Juliana Monte Real, Ludmila Rodrigues Pinto Ferreira, Gustavo H. Esteves, Fabio do Nascimento Brito & Otavio C.G. Baiocchi. (2018) Soluble PD-1 and PD-L1 as potential biomarkers for classical Hodgkin lymphoma. Hematological Oncology 36:4, pages 709-712.
Crossref
Crossref